Waleed Alqurashi

Investigator, CHEO Research Institute

Dr. Waleed Alqurashi completed his pediatric residency training at the Montreal Children’s Hospital and McGill University and his fellowship training in pediatric emergency medicine at the Children’s Hospital of Eastern Ontario (CHEO) and the University of Ottawa. He then completed a Master’s degree in Clinical Epidemiology at the University of Ottawa while doing a research fellowship at The Ottawa Hospital Research Institute. He also completed the Society for Academic Emergency Medicine (SAEM) research fellowship. He joined the Division of Emergency Medicine at CHEO and the Department of Emergency Medicine at the University of Ottawa in 2013. Since then, he has been a clinical investigator at the CHEO Research Institute. He secured research funding and published scholarly projects related to allergic reactions and anaphylaxis, with a particular focus on biphasic anaphylaxis, anaphylaxis epidemiology, and anaphylaxis related patient education materials.

He is a member of the CHEO Antibiotic Stewardship Program and leading a penicillin de-labelling project in the Emergency Department. Dr. Alqurashi is the Content Advisor for anaphylaxis at the Translating Emergency Knowledge for Kids (TREKK), a national centre of excellence aimed at bringing evidence-based pediatric emergency care to general emergency departments across Canada. He is also a member of the Editorial Board of the TREKK network.

Related News

Research Projects

  1. Skin Testing for Penicillin Allergy: a Review of the Literature


    This review provides support for risk stratification assessment of reported penicillin allergy to optimize antibiotic use and prevent emergence of antimicrobial resistance.

  2. Management of pediatric allergic reaction: Practice patterns of Canadian pediatric emergency physicians


    Most respondents recognized cases of anaphylaxis; however, a substantial number demonstrated gaps in management that may adversely impact this vulnerable population. The recognition of anaphylaxis without urticaria or pulmonary findings and treatment of anaphylaxis with epinephrine, where indicated, were the main gaps identified.

  3. The Canadian anaphylaxis action plan for kids: development and validation


    The Kids’ CAP is a useful educational tool to improve patient’s comprehension of anaphylaxis management.

  4. Do Corticosteroids Prevent Biphasic Anaphylaxis?


    Corticosteroids are thought by some to prevent the development of biphasic symptoms and, therefore, commonly used in the emergency treatment of anaphylaxis but this has not been systemtically analyzed.

  5. Epidemiology and clinical predictors of biphasic reactions in children with anaphylaxis


    Biphasic reactions seem to be associated with the severity of the initial anaphylactic reactions. We identified clinical predictors that could ultimately be used to identify patients who would benefit from prolonged ED monitoring and enable better utilization of ED resources.